Shilpa Medicare Limited (SHILPAMED) — Financial Results | 3 July 2026

StockFin.ai

Try Free

Shilpa Medicare Limited reported FY2026 revenue of [amount not verified] and net profit of [amount not verified], up sharply from [amount not verified] profit in Q1 FY2026. The company proposed a Re. 0.60 per share dividend and approved a 28% equity stake in Neo Green Power for captive renewable power. Auditor V.J. Talati & Co was appointed for FY2026-27.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SHILPAMED ✨ Ask AI About This

About Shilpa Medicare Limited (SHILPAMED)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹9,356.63 Cr P/E: 106.1

View full SHILPAMED stock details →

📡 Get AI alerts when SHILPAMED files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SHILPAMED — Free

💡 Ask AI about this filing

"How does this financial results affect Shilpa Medicare Limited's outlook?" "What did Shilpa Medicare Limited announce on 3 July 2026?" "Is this positive or negative for SHILPAMED?"

Ask AI Free →

📊 More SHILPAMED filings

See all SHILPAMED filings →

🔥 Also filed on 3 July 2026

PRESTIGE Prestige Estates Projects Limited Announcement PROZONER Prozone Realty Limited Announcement PRUDENT Prudent Corporate Advisory Services Limited Annual Report PTL PTL Enterprises Limited Annual Report RADIOCITY Music Broadcast Limited Announcement RBLBANK RBL Bank Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when SHILPAMED files new disclosures

Track SHILPAMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SHILPAMED — Free

Free account · 2 AI queries/day